Medicare Compliance & Reimbursement - 2004 Issue 10
Chemotherapy: Don't Bill Level 1 Office Visits With Chemo
Subscribe or sign in to view the full article.
Article Overview
This article covers Medicare physician fee schedule guidance affecting billing on chemotherapy and infusion days. It discusses the relationship between evaluation and management services, administration services, documentation, medical necessity, and use of modifier -25 in the context of oncology practice. The piece is relevant to coders, billers, oncology practices, and compliance staff who need to understand how these services are treated together under current Medicare guidance.
Why This Topic Matters
The topic affects whether offices can report separate E/M services on infusion days and how they document and code oncology encounters for Medicare reimbursement.
What You Will Learn
- How Medicare guidance affects billing on chemotherapy and infusion service dates
- When a separately identifiable E/M service may be considered for reporting
- Why documentation and medical necessity matter for same-day reporting
- How modifier -25 is discussed in relation to infusion and E/M services
- How oncology coding staff may need to review fee schedule changes and payer rules
Who Should Read This
- Medical coders
- Medical billers
- Oncology practice staff
- Compliance professionals
- Physician revenue cycle teams
Codes Discussed
Code Ranges Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com